← Back to Search

Radiation

Automated MR-Guided Radiation for Breast Cancer

N/A

Waitlist Available

Led By Robert Dinniwell, M.D.

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who will receive standard two-field tangential whole breast radiation therapy with dose prescription of 4240 cGy in 16 fractions, 5000 cGy in 25 fractions or 4000 cGy in 16 fractions

≥ 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial is investigating the feasibility of using automated planning tools with a new MR-guided linac to do on-line adaptive radiation treatment for early stage breast cancer patients.

Who is the study for?

This trial is for female patients over 18 with any stage of breast cancer, who will undergo standard whole breast radiation therapy. It's open to those who've had surgery or chemotherapy for any cancer type and can consent in writing.Check my eligibility

What is being tested?

The study tests an automated planning tool that uses MR images from a new MR-guided linac for on-line adaptive radiation treatment, aiming to refine this technology and validate its clinical use without extra ionizing radiation.See study design

What are the potential side effects?

While the document doesn't specify side effects, typical ones from IMRT (radiation therapy) may include skin irritation, fatigue, swelling in the treated area, and changes in breast size or shape.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I will receive standard breast radiation therapy in one of the specified dose plans.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The effect of breathing on the position of the heart and lung in treatment plans

Time between planning of Radiation treatment and the start of radiotherapy

Trial Design

1Treatment groups

Experimental Treatment

Group I: IMRT + CT + MR scanExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,468 Previous Clinical Trials

484,330 Total Patients Enrolled

53 Trials studying Breast Cancer

29,394 Patients Enrolled for Breast Cancer

Princess Margaret Hospital, CanadaOTHER

119 Previous Clinical Trials

38,899 Total Patients Enrolled

11 Trials studying Breast Cancer

22,687 Patients Enrolled for Breast Cancer

Robert Dinniwell, M.D.Principal InvestigatorPrincess Margaret Cancer Centre

Media Library

Breast Cancer Research Study Groups: IMRT + CT + MR scan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently seeking volunteers for this clinical trial?

"According to clinicaltrials.gov, this trial has concluded its search for patients after initially being posted on March 1st 2013 and last edited October 6th 2022. Nonetheless, there are 1404 other studies actively recruiting right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Automated Breast Radiation Therapy Using an MR-Guided Process

2013. "Automated Breast Radiation Therapy Using an MR-Guided Process". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01999062.

All > Womens Health